The Current Ratio as of December 2024 (TTM) for Olink Holding AB (publ) (OLK) is 5.60

According to Olink Holding AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 5.60. This represents a change of -7.09% compared to the average of 6.03 of the last 4 quarters.

Olink Holding AB (publ) (OLK) Historical Current Ratio (quarterly & annually)

How has OLK Current Ratio performed in the past?

The mean historical Current Ratio of Olink Holding AB (publ) over the last ten years is 3.84. The current 5.60 Current Ratio has changed 14.48% with respect to the historical average. Over the past ten years (40 quarters), OLK's Current Ratio was at its highest in in the September 2021 quarter at 8.39. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Olink Holding AB (publ) (OLK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Olink Holding AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Olink Holding AB (publ) (OLK) Average Current Ratio

How has OLK Current Ratio performed in the past?

The current Current Ratio of Olink Holding AB (publ) (OLK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Olink Holding AB (publ) (OLK) Current Ratio vs. Peers

How is OLK’s Current Ratio compared to its peers?

Olink Holding AB (publ)’s Current Ratio is less than FONAR Corporation (9.64), greater than Burning Rock Biotech Limited (3.04), greater than Sera Prognostics, Inc. (2.11), greater than LumiraDx Limited (2.91), greater than Genetron Holdings Limited (0), greater than Psychemedics Corporation (1.59), greater than DarioHealth Corp. (1.57), greater than Neuronetics, Inc. (3.16), less than Castle Biosciences, Inc. (7.78), greater than Exagen Inc. (4.05), greater than Neogen Corporation (4.41), greater than Qiagen N.V. (2.17), less than Aclaris Therapeutics, Inc. (7.03), greater than Syneos Health, Inc. (1.13),

Build a custom stock screener for Olink Holding AB (publ) (OLK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Olink Holding AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Olink Holding AB (publ) (OLK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Olink Holding AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.